ARIX.L Regulatory News (ARIX)

ARIX.L Information

There is currently no data for ARIX

Holding(s) in Company

24 Jan 2024 17:30

Arix Bioscience PLC (ARIX) Holding(s) in Company 24-Jan-2024 / 17:30 GMT/BST

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BDO45071

Issuer Name

Arix Bioscience plc

UK or Non-UK Issuer

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Acacia Research Corporation

City of registered office (if applicable)

Country of registered office (if applicable)

4. Details of the shareholder

Name	City of registered office	Country of registered office
Merton Acquisition Holdco LLC	New York	United States

5. Date on which the threshold was crossed or reached

19-Jan-2024

6. Date on which Issuer notified

24-Jan-2024

7. Total positions of person(s) subject to the notification obligation

.	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	0.000000	0.000000	0.000000	0
Position of previous notification (if applicable)	25.563559	0.000000	25.563559

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB00BD045071	0		0.000000
Sub Total 8.A	0		0.000000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Acacia Research Corporation	Merton Acquisition Holdco LLC	0.000000		0.000000%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

Merton Acquisition Holdco LLC is a wholly owned subsidiary of Acacia Research Corporation.

12. Date of Completion

24-Jan-2024

13. Place Of Completion

New York, New York, USA

Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


ISIN:	GB00BD045071
Category Code:	HOL
TIDM:	ARIX
LEI Code:	213800OVT3AHQCXNIX43
OAM Categories:	2.3. Major shareholding notifications
Sequence No.:	299503
EQS News ID:	1822383


End of Announcement	EQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date		Source	Headline
28th May 2021	4:56 pm	EQS	Transaction in own shares
27th May 2021	4:58 pm	EQS	Transaction in own shares
26th May 2021	4:53 pm	EQS	Transaction in own shares
25th May 2021	5:24 pm	EQS	Transaction in own shares
24th May 2021	5:04 pm	EQS	Transaction in own shares
21st May 2021	5:09 pm	EQS	Transaction in own shares
20th May 2021	5:27 pm	EQS	Transaction in own shares
20th May 2021	7:00 am	EQS	Change of registered office
19th May 2021	5:06 pm	EQS	Transaction in own shares
18th May 2021	5:33 pm	EQS	Transaction in own shares
18th May 2021	7:00 am	EQS	Notice of 2021 Annual General Meeting
17th May 2021	5:40 pm	EQS	Transaction in own shares
14th May 2021	5:02 pm	EQS	Transaction in own shares
13th May 2021	5:16 pm	EQS	Transaction in own shares
12th May 2021	5:12 pm	EQS	Transaction in own shares
12th May 2021	4:35 pm	EQS	Autolus to present additional data in AUTO1 in IBCL
11th May 2021	5:43 pm	EQS	Transaction in own shares
10th May 2021	5:21 pm	EQS	Transaction in own shares
7th May 2021	5:19 pm	EQS	Transaction in own shares
6th May 2021	5:23 pm	EQS	Transaction in own shares
5th May 2021	5:16 pm	EQS	Transaction in own shares
4th May 2021	5:15 pm	EQS	Transaction in own shares
4th May 2021	7:00 am	EQS	Total Voting Rights
30th Apr 2021	4:59 pm	EQS	Transaction in own shares
30th Apr 2021	7:00 am	EQS	Outcome of Strategic Implementation Review and Directorate Change
29th Apr 2021	5:10 pm	EQS	Transaction in own shares
28th Apr 2021	5:14 pm	EQS	Transaction in own shares
28th Apr 2021	12:02 pm	EQS	Amplyx Pharmaceuticals acquired by Pfizer
27th Apr 2021	5:29 pm	EQS	Transaction in own shares
27th Apr 2021	2:00 pm	EQS	LogicBio announces clinical and corporate updates
26th Apr 2021	5:32 pm	EQS	Transaction in own shares
23rd Apr 2021	5:11 pm	EQS	Transaction in own shares
22nd Apr 2021	5:15 pm	EQS	Transaction in own shares
21st Apr 2021	5:27 pm	EQS	Transaction in own shares
20th Apr 2021	5:31 pm	EQS	Transaction in own shares
19th Apr 2021	5:09 pm	EQS	Transaction in own shares
16th Apr 2021	5:18 pm	EQS	Transaction in own shares
15th Apr 2021	5:09 pm	EQS	Transaction in own shares
14th Apr 2021	5:13 pm	EQS	Transaction in own shares
13th Apr 2021	5:13 pm	EQS	Transaction in own shares
12th Apr 2021	5:23 pm	EQS	Transaction in own shares
9th Apr 2021	5:44 pm	EQS	Transaction in own shares
8th Apr 2021	5:28 pm	EQS	Transaction in own shares
8th Apr 2021	8:19 am	RNS	Proactive One2One Virtual Investor Forum
8th Apr 2021	7:00 am	EQS	Arix to Present at the Proactive One2One Virtual Investor Forum
7th Apr 2021	5:47 pm	EQS	Transaction in own shares
7th Apr 2021	7:00 am	EQS	Artios announces collaboration with Novartis to create next generation DDR cancer therapies
6th Apr 2021	5:26 pm	EQS	Transaction in own shares
1st Apr 2021	5:20 pm	EQS	Transaction in own shares
1st Apr 2021	7:00 am	EQS	Total Voting Rights

Latest Share Chat

ARIX.L Regulatory News (ARIX)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

Login to your account

Quickpicks are a member only feature

Login to your account